HER2-positive Breast Cancer Registry
Recruiting · NCT06603597 · Observational (researchers observe without assigning treatment) · Lead sponsor: Priyanka Sharma
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Stage I-IV HER2-positive breast cancer
Exclusion criteria
- None
Where it is running
6 locations listed across 2 US states.
- KUCC - Indian Creek - Overland Park, Kansas, United States
- KUCC - Overland Park - Overland Park, Kansas, United States
- KUCC - Briarcliff - Westwood, Kansas, United States
- KUCC - Olathe - Westwood, Kansas, United States
- The University of Kansas Cancer Center - Westwood, Kansas, United States
- KUCC - Lee's Summit - Lee's Summit, Missouri, United States